23rd American Pharma & Biotech Project, Program and Portfolio Conference

16–18 Oct 2024 | Boston, Massachusetts, United States

Wednesday, 16 October 2024 | 14:00 - 15:00

KEYNOTE FOLLOWED BY A PANEL DISCUSSION: Optimizing portfolio based on risk and return assessment

Format:In-personLocation:Beacon Hill Ballroom
  • Assessing Portfolio Risk

In this panel discussions we will explore several approaches that helped biotech and pharma companies to optimize the portfolio: Based on the risk and return assessment, identifying opportunities to optimize the portfolio. This involves adjusting resource allocations, prioritizing or deprioritizing certain projects, or pursuing new partnerships or collaborations to mitigate risks or enhance returns.

Hosted by

CAPTARIO

Gothenburg, Sweden

4 speakers

  • Mike Fitzpatrick

    Vice President of Business Development & Operations

    Umoja Biopharma

  • Chris Kramer

    Vice President of Portfolio Planning & Market Insights

    Ionis Pharmaceuticals

  • Ivan Kugener

    VP, Head of Global Portfolio Management, Valuation & Analytics

    EMD Serono

  • Magnus Ytterstad

    VP of Product & Customer Success

    Captario

Location image

Session location Beacon Hill Ballroom